Clinical Trial Update: Glutamine in Treating Neuropathy Caused by Vincristine in Young Patients With Lymphoma, Leukemia, or Solid Tumors [Phase 2]

View source ↗

Summary

Phase 2 trial evaluates glutamine for vincristine-induced neuropathy in pediatric patients with lymphoma, leukemia, or solid tumors. The study has been complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Cancer
• Leukemia
• Lymphoma
• Sarcoma

Drugs mentioned

• Glutamine (glutamine)
• Vincristine (vincristine)

Snippet

Sponsor: Columbia University | Conditions: Kidney Cancer, Leukemia | Phase 2 | Status: COMPLETED | Results posted: 2016-09-09